UK-based medical devices company MatOrtho has made two new commercial appointments.
Tim Lawes has joined the business as vice president of global marketing and David Clapcott has been appointed vice president of global sales following investment by Connection Capital LLP.
Lawes will take on responsibility for devising and implementing commercial strategies to drive further uptake and adoption of existing products in the company’s hip and knee portfolio, as well as shape the development and commercialisation strategy of emerging products and technologies.
In his new role, Clapcott will be responsible for growing the existing portfolio of hip and knee products on a global basis, reshaping existing field resources, guiding investment in new market entry and ensuring key opinion leaders around the world understand the role MatOrtho’s products can play in helping address their patients’ needs.
MatOrtho non-executive director Simon Cartmell said: ‘We are thrilled to welcome both David and Tim to MatOrtho. They bring unparalleled expertise to the company at a key time. We are embarking on a new phase of growth post Covid, as elective surgeries return to previous levels and as global experience reinforces the unsurpassed clinical performance of our hip and knee reconstruction products.’
Carter Schwartz’s head of practice, private equity, Lewis Buckley, who previously advised on Cartmell’s appointment, advised on the appointments.